- Aging
- Brands
- Business
- conjoint
- Consumers
- COVID
- criminal justice
- Culture
- economy
- Education
- Employment
- Entertainment
- environment
- experiment
- Family
- food
- Gradient In The Wild
- health & wellness
- Holiday
- Inside Gradient
- Leisure
- lifestyle
- List Experiment
- MaxDiff
- message-testing
- Movies
- music
- Out There
- Personality
- politics
- Relationships
- Research & Development
- retrospective
- Science
- Seasonal
- segmentation
- Society
- Sports
- Tech
- travel
- TrendSegments
- World
The Gender “Return to Normal” Gap
We’re getting there, folks. As of June 1st, 51% of all Americans (including children) have gotten at least one dose of the vaccine including 41% who are fully vaccinated, ...
Tesla Stock: Asset Bubble or Champagne Bubble?
Tesla — the most valuable car company in the world — is estimated to be worth more than $700 billion, but produced fewer cars than the next most valuable competitor, Toyota, by a ...
Easy Come, (Not So) Easy Go
In early March, Senate Democrats pushed a $1.9 trillion Covid relief bill in a party-line vote through budget reconciliation. A large portion – $410 billion – of that hefty price ...
Ramp Up to Get Down
Even while vaccine distribution has, at times, sputtered, U.S. state and federal officials are channeling their inner-Jimmy John’s, delivering roughly 1.5 million shots in arms ...
GameStop Won’t Stop
Now that the news cycle has oxygen to cover other interesting things happening in the world, said oxygen has been sucked up by a topic that most Americans would, on a normal day, ...
Herd Mentality
We’re very excited (...eager...giddy, even) to announce that we are retiring one of our monthly tracked data points: the expected timing of a COVID-19 vaccine. Thanks to a couple ...
Are We There Yet? … Actually, Yes, Almost
In case you weren’t aware, the pandemic is still a thing. November 4th came and went; and no, the virus didn’t “go away.” In fact, the United States is hitting record numbers of ...
Did Someone Move the Finish Line?
Finally, We’ve (Sort of) Plateaued
Our monthly tracking of expectations for the economy to resume normal economic activity and the availability of a vaccine has finally, finally leveled. And we even see a glimpse ...